You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
昂利康(002940.SZ)放棄湖南新合新生物醫藥增資優先認購權
格隆匯 06-26 16:56

格隆匯6月26日丨昂利康(002940.SZ)發佈公吿,公司參股公司湖南新合新生物醫藥有限公司為滿足發展需求,擬進行增資,湖南玖康創業投資合夥企業(有限合夥)、長沙麓谷資本管理有限公司、湖南泊富文化產業投資基金企業(有限合夥)、長沙上善新富創業投資合夥企業(有限合夥)、深圳宏典盛世醫藥投資合夥企業(有限合夥)、杭州曉池飛鴻創業投資合夥企業(有限合夥)、湖南泊富悦盈企業管理合夥企業(有限合夥)(以上合稱“增資方”)擬參與本次增資,經各方協商一致,本次增資價格為41.60元/單位註冊資本,合計共增資19,807.4128萬元,其中476.1397萬元計入註冊資本,19,331.2731萬元計入資本公積金。公司對新合新本次增資享有優先認購權,根據公司實際情況,公司擬放棄本次增資優先認購權。本次增資前,公司持有新合新12.55%股權,系公司參股公司,本次增資結束後,公司持有新合新股權比例降至11.16%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account